Advances in antibiotic and microbiome-based therapies may reduce recurrence and improve outcomes in patients with recurrent Clostridioides difficile infection.
John Bomkamp, PharmD, BCIDP, AAHIVP
Advertisement
Articles by John Bomkamp, PharmD, BCIDP, AAHIVP
Advertisement
Latest Updated Articles
Advertisement
Advertisement